Fonar Corporation (FONR): Price and Financial Metrics

Fonar Corporation (FONR): $15.40

0.45 (-2.84%)

POWR Rating

Component Grades








FONR Price/Volume Stats

Current price $15.40 52-week high $19.00
Prev. close $15.85 52-week low $13.73
Day low $15.12 Volume 22,800
Day high $15.93 Avg. volume 9,980
50-day MA $16.42 Dividend yield N/A
200-day MA $16.83 Market Cap 100.69M

FONR Stock Price Chart Interactive Chart >


  • Stability is the dimension where FONR ranks best; there it ranks ahead of 99.5% of US stocks.
  • The strongest trend for FONR is in Growth, which has been heading up over the past 177 days.
  • FONR's current lowest rank is in the Momentum metric (where it is better than 28.39% of US stocks).

FONR Stock Summary

  • Of note is the ratio of FONAR CORP's sales and general administrative expense to its total operating expenses; 79.31% of US stocks have a lower such ratio.
  • FONR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 16.84% of US stocks.
  • The volatility of FONAR CORP's share price is greater than that of merely 6.55% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to FONR, based on their financial statements, market capitalization, and price volatility, are NSYS, DXLG, GLG, TANH, and SNBR.
  • FONR's SEC filings can be seen here. And to visit FONAR CORP's official web site, go to

FONR Valuation Summary

  • In comparison to the median Healthcare stock, FONR's price/earnings ratio is 57.68% lower, now standing at 11.3.
  • Over the past 243 months, FONR's price/earnings ratio has gone up 17.8.

Below are key valuation metrics over time for FONR.

Stock Date P/S P/B P/E EV/EBIT
FONR 2023-09-22 1.1 0.7 11.3 7.1
FONR 2023-09-21 1.1 0.7 11.3 7.1
FONR 2023-09-20 1.1 0.7 11.4 7.1
FONR 2023-09-19 1.1 0.7 11.5 7.2
FONR 2023-09-18 1.1 0.7 11.2 7.0
FONR 2023-09-15 1.1 0.7 11.0 6.9

FONR Growth Metrics

    The year over year cash and equivalents growth rate now stands at 12.74%.
  • Its 3 year net income to common stockholders growth rate is now at -46.82%.
  • The 2 year net cashflow from operations growth rate now stands at -20.66%.
FONR's revenue has moved up $9,462,258 over the prior 34 months.

The table below shows FONR's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-12-31 96.83015 15.36836 8.281796
2022-09-30 97.05315 16.75736 9.961796
2022-06-30 97.59215 15.30136 11.6908
2022-03-31 97.47576 16.065 10.25913
2021-12-31 95.99477 15.331 11.74013
2021-09-30 92.68076 16.547 10.88913

FONR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • FONR has a Quality Grade of B, ranking ahead of 88.69% of graded US stocks.
  • FONR's asset turnover comes in at 0.487 -- ranking 97th of 186 Medical Equipment stocks.
  • SMLR, STXS, and BMRA are the stocks whose asset turnover ratios are most correlated with FONR.

The table below shows FONR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.487 0.483 0.095
2021-03-31 0.472 0.503 0.077
2020-12-31 0.474 0.508 0.066
2020-09-30 0.482 0.505 0.064
2020-06-30 0.497 0.495 0.069
2020-03-31 0.543 0.477 0.094

Fonar Corporation (FONR) Company Bio

Fonar Corporation engages in the design, manufacture, sale, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, and other medical conditions and injuries. It operates in two segments, Medical Equipment, and Physician and Diagnostic Services Management. The company was founded in 1978 and is based in Melville, New York.

FONR Latest News Stream

Event/Time News Detail
Loading, please wait...

FONR Latest Social Stream

Loading social stream, please wait...

View Full FONR Social Stream

Latest FONR News From Around the Web

Below are the latest news stories about FONAR CORP that investors may wish to consider to help them evaluate FONR as an investment opportunity.

FONAR Announces Financial Results for Fiscal 2023

On August 3, 2022, FONAR founder and The Father of MRI, Raymond V. Damadian, died at 86. At the time of his passing, Dr. Damadian was FONAR's Chairman of the Board. Timothy R. Damadian, FONAR's president and CEO since 2016 has been elected as Chairman of the Board.On September 13, 2022, the Company adopted a stock repurchase plan of up to $9 million. Total MRI scan volume at the HMCA-managed sites increased 1% ...

Yahoo | September 28, 2023

Pleasing Signs As A Number Of Insiders Buy FONAR Stock

Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like...

Yahoo | September 4, 2023

7 Bargain Stocks to Snatch Up Before They Bounce Back in the Second Half

While the best discounts may have faded in the spring of 2020, there are still bargain stocks to buy for adventurous investors.

Josh Enomoto on InvestorPlace | July 25, 2023

Some Investors May Be Worried About FONAR's (NASDAQ:FONR) Returns On Capital

If you're looking for a multi-bagger, there's a few things to keep an eye out for. One common approach is to try and...

Yahoo | July 15, 2023

FONAR Corporation's (NASDAQ:FONR) top owners are retail investors with 49% stake, while 46% is held by institutions

Key Insights FONAR's significant retail investors ownership suggests that the key decisions are influenced by...

Yahoo | June 7, 2023

Read More 'FONR' Stories Here

FONR Price Returns

1-mo -5.98%
3-mo N/A
6-mo -3.63%
1-year 8.83%
3-year -29.00%
5-year -37.01%
YTD -8.06%
2022 11.82%
2021 -13.71%
2020 -11.83%
2019 -2.72%
2018 -16.88%

Continue Researching FONR

Want to see what other sources are saying about Fonar Corp's financials and stock price? Try the links below:

Fonar Corp (FONR) Stock Price | Nasdaq
Fonar Corp (FONR) Stock Quote, History and News - Yahoo Finance
Fonar Corp (FONR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!